Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
ME3738 is a new compound that attenuates liver disease in several models of acute and chronicliverinflammation.
2
Background: Hepatitis C infection induces an acute and chronicliverinflammation that may lead to cirrhosis, liver failure, or hepatocarcinoma.
1
One patient with recurrenthepatitis B developed chronic severe hepatitis B despite treatment.
2
The severity of recurrenthepatitis C virus (HCV) is likely related to several factors.
3
Methods: Twenty-nine cases of recurrenthepatitis C and 26 cases of ACR were included in this study.
4
One patient died of recurrenthepatitis C and graft failure without evidence of tuberculous infection at death.
5
Conclusions: Improving the outcome of recurrenthepatitis C may be achieved by reducing overall immunosuppression and avoiding abrupt variations in immunosuppression.
Использование термина chronic hepatitis на английском
1
Gilead said chronichepatitis B affects more than 400 million people worldwide.
2
Methods: One hundred forty-two unselected patients with chronichepatitis C were included.
3
Conclusions: Entecavir therapy showed excellent efficacy in nucleoside-naive chronichepatitis B patients.
4
Background and aim: Entecavir has demonstrated clinical efficacy for chronichepatitis B.
5
This review focuses on the current treatment concepts for chronichepatitis B.
6
Hepatic form is manifested by acute or chronichepatitis, steatosis or cirrhosis.
7
Crescentic glomerulonephritis was diagnosed in two chronichepatitis B surface antigen carriers.
8
All biopsies showed chronichepatitis, of which 2 were associated with cirrhosis.
9
Methods: One hundred and twelve patients with biopsy-proven chronichepatitis C were enrolled.
10
Aim: Predict the elimination of chronichepatitis C in Catalan prisons.
11
The course of chronichepatitis C is variable, but usually fibrosis advances slowly.
12
Comprehensive management of chronichepatitis C takes into account cofactors of disease progression.
13
Twelve patients with chronichepatitis C were included in the study.
14
Despite the declining incidence of acute HCV infection, chronichepatitis C is common.
15
Current therapy for HCV-related chronichepatitis is based on the use of interferon.
16
A hallmark of chronichepatitis B is a dysfunctional HBV-specific T cell response.